Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,181,411 results for ""Costs""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Market Transparency in Medicine Pricing: Pathways to Fair Pricing.

  • Authors : Carapinha JL; Syenza, Anaheim, CA, USA. .; School of Pharmacy and Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA. .

Subjects: Drug Costs* ; Drug Industry*/Drug Industry*/Drug Industry*/economics; Humans

  • Source: PharmacoEconomics [Pharmacoeconomics] 2024 Jun; Vol. 42 (6), pp. 611-614. Date of Electronic Publication: 2024 May 09.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Editorial & Opinion

Learnings from cross-border biosimilar pricing policies in Europe.

  • Authors : Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Lacosta TB

Subjects: Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/economics ; Drug Costs*; Humans

  • Source: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Jun; Vol. 24 (5), pp. 585-588. Date of Electronic Publication: 2024 Mar 26.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe.

  • Authors : Dzingirai B; Unit of Global Health, Department of Health Sciences, Üniversity of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.

Subjects: Tertiary Care Centers*/Tertiary Care Centers*/Tertiary Care Centers*/economics ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/economics ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/administration & dosage

  • Source: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Jun; Vol. 24 (5), pp. 687-695. Date of Electronic Publication: 2024 May 08.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

What is a fair price for a medicine? Establishing the main elements of a fair price based on the current policy debate.

  • Authors : Roediger A; Department of International Health, Care and Public Health Research Institute - CAPHRI, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. Electronic address: .; Schönbächler G

Subjects: Drug Costs*; Humans ; Health Policy

  • Source: Public health [Public Health] 2024 Jun; Vol. 231, pp. 148-153. Date of Electronic Publication: 2024 Apr 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376507 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Addressing methodological concerns in analysing direct cost: Letter to the Editor.

  • Authors : Cherif H; Pulmonology department. Internal security forces hospital. University of Tunis El Manar. Faculty of medicine of Tunis. Tunisia.

Subjects: Health Care Costs*/Health Care Costs*/Health Care Costs*/statistics & numerical data; Humans ; Costs and Cost Analysis

  • Source: La Tunisie medicale [Tunis Med] 2024 May 05; Vol. 102 (5), pp. 255. Date of Electronic Publication: 2024 May 05.Publisher: Societe Tunisienne Des Sciences Medicales Country of Publication: Tunisia NLM ID: 0413766 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Comment on: A Framework for the Fair Pricing of Medicines.

  • Authors : Babar ZU; Department of Pharmacy, University of Huddersfield, Huddersfield, UK. .

Subjects: Drug Costs*; Humans ; Pharmaceutical Preparations/Pharmaceutical Preparations/Pharmaceutical Preparations/economics

  • Source: PharmacoEconomics [Pharmacoeconomics] 2024 May; Vol. 42 (5), pp. 605-606. Date of Electronic Publication: 2024 Mar 13.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Estimating the cost of sports injuries: A scoping review.

  • Authors : Turnbull MR; University of Canberra Research Institute for Sport and Exercise (UCRISE), Australia. Electronic address: .; Gallo TF

Subjects: Athletic Injuries*/Athletic Injuries*/Athletic Injuries*/economics ; Health Care Costs*/Health Care Costs*/Health Care Costs*/statistics & numerical data; Humans

  • Source: Journal of science and medicine in sport [J Sci Med Sport] 2024 May; Vol. 27 (5), pp. 307-313. Date of Electronic Publication: 2024 Mar 08.Publisher: Elsevier Australia Country of Publication: Australia NLM ID: 9812598 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Reply to Comment on "A Framework for Fair Pricing of Medicines".

  • Authors : Paulden M; School of Public Health, University of Alberta, 11405 87 Ave, Edmonton, AB, T6G 1C9, Canada. .

Subjects: Drug Costs*; Humans ; Costs and Cost Analysis

  • Source: PharmacoEconomics [Pharmacoeconomics] 2024 May; Vol. 42 (5), pp. 607-609. Date of Electronic Publication: 2024 Mar 13.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Global Barriers to Accessing Off-Patent Endocrine Therapies: A Renaissance of the Orphan Disease?

  • Authors : de Silva NL; Department of Clinical Sciences, Faculty of Medicine, General Sir John Kotelawala Defence University, Ratmalana 10390, Sri Lanka.; Dissanayake H

Subjects: Drug Costs* ; Rare Diseases*/Rare Diseases*/Rare Diseases*/drug therapy; Humans

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Apr 19; Vol. 109 (5), pp. e1379-e1388.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Diagnosing and characterizing inflammatory myopathies at an Australian tertiary public hospital: Resource utilization and direct healthcare costs.

  • Authors : Huang V; Department of Rheumatology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.; Ciciriello S

Subjects: Myositis*/Myositis*/Myositis*/diagnosis ; Myositis*/Myositis*/Myositis*/economics ; Myositis*/Myositis*/Myositis*/therapy

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Apr; Vol. 27 (4), pp. e15153.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,181,411 results for ""Costs""